Cargando…

Development of a Biodegradable Subcutaneous Implant for Prolonged Drug Delivery Using 3D Printing

Implantable drug delivery devices offer many advantages over other routes of drug delivery. Most significantly, the delivery of lower doses of drug, thus, potentially reducing side-effects and improving patient compliance. Three dimensional (3D) printing is a flexible technique, which has been subje...

Descripción completa

Detalles Bibliográficos
Autores principales: Stewart, Sarah A., Domínguez-Robles, Juan, McIlorum, Victoria J., Mancuso, Elena, Lamprou, Dimitrios A., Donnelly, Ryan F., Larrañeta, Eneko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076405/
https://www.ncbi.nlm.nih.gov/pubmed/32013052
http://dx.doi.org/10.3390/pharmaceutics12020105
_version_ 1783507209084207104
author Stewart, Sarah A.
Domínguez-Robles, Juan
McIlorum, Victoria J.
Mancuso, Elena
Lamprou, Dimitrios A.
Donnelly, Ryan F.
Larrañeta, Eneko
author_facet Stewart, Sarah A.
Domínguez-Robles, Juan
McIlorum, Victoria J.
Mancuso, Elena
Lamprou, Dimitrios A.
Donnelly, Ryan F.
Larrañeta, Eneko
author_sort Stewart, Sarah A.
collection PubMed
description Implantable drug delivery devices offer many advantages over other routes of drug delivery. Most significantly, the delivery of lower doses of drug, thus, potentially reducing side-effects and improving patient compliance. Three dimensional (3D) printing is a flexible technique, which has been subject to increasing interest in the past few years, especially in the area of medical devices. The present work focussed on the use of 3D printing as a tool to manufacture implantable drug delivery devices to deliver a range of model compounds (methylene blue, ibuprofen sodium and ibuprofen acid) in two in vitro models. Five implant designs were produced, and the release rate varied, depending on the implant design and the drug properties. Additionally, a rate controlling membrane was produced, which further prolonged the release from the produced implants, signalling the potential use of these devices for chronic conditions.
format Online
Article
Text
id pubmed-7076405
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70764052020-03-24 Development of a Biodegradable Subcutaneous Implant for Prolonged Drug Delivery Using 3D Printing Stewart, Sarah A. Domínguez-Robles, Juan McIlorum, Victoria J. Mancuso, Elena Lamprou, Dimitrios A. Donnelly, Ryan F. Larrañeta, Eneko Pharmaceutics Article Implantable drug delivery devices offer many advantages over other routes of drug delivery. Most significantly, the delivery of lower doses of drug, thus, potentially reducing side-effects and improving patient compliance. Three dimensional (3D) printing is a flexible technique, which has been subject to increasing interest in the past few years, especially in the area of medical devices. The present work focussed on the use of 3D printing as a tool to manufacture implantable drug delivery devices to deliver a range of model compounds (methylene blue, ibuprofen sodium and ibuprofen acid) in two in vitro models. Five implant designs were produced, and the release rate varied, depending on the implant design and the drug properties. Additionally, a rate controlling membrane was produced, which further prolonged the release from the produced implants, signalling the potential use of these devices for chronic conditions. MDPI 2020-01-28 /pmc/articles/PMC7076405/ /pubmed/32013052 http://dx.doi.org/10.3390/pharmaceutics12020105 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Stewart, Sarah A.
Domínguez-Robles, Juan
McIlorum, Victoria J.
Mancuso, Elena
Lamprou, Dimitrios A.
Donnelly, Ryan F.
Larrañeta, Eneko
Development of a Biodegradable Subcutaneous Implant for Prolonged Drug Delivery Using 3D Printing
title Development of a Biodegradable Subcutaneous Implant for Prolonged Drug Delivery Using 3D Printing
title_full Development of a Biodegradable Subcutaneous Implant for Prolonged Drug Delivery Using 3D Printing
title_fullStr Development of a Biodegradable Subcutaneous Implant for Prolonged Drug Delivery Using 3D Printing
title_full_unstemmed Development of a Biodegradable Subcutaneous Implant for Prolonged Drug Delivery Using 3D Printing
title_short Development of a Biodegradable Subcutaneous Implant for Prolonged Drug Delivery Using 3D Printing
title_sort development of a biodegradable subcutaneous implant for prolonged drug delivery using 3d printing
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076405/
https://www.ncbi.nlm.nih.gov/pubmed/32013052
http://dx.doi.org/10.3390/pharmaceutics12020105
work_keys_str_mv AT stewartsaraha developmentofabiodegradablesubcutaneousimplantforprolongeddrugdeliveryusing3dprinting
AT dominguezroblesjuan developmentofabiodegradablesubcutaneousimplantforprolongeddrugdeliveryusing3dprinting
AT mcilorumvictoriaj developmentofabiodegradablesubcutaneousimplantforprolongeddrugdeliveryusing3dprinting
AT mancusoelena developmentofabiodegradablesubcutaneousimplantforprolongeddrugdeliveryusing3dprinting
AT lamproudimitriosa developmentofabiodegradablesubcutaneousimplantforprolongeddrugdeliveryusing3dprinting
AT donnellyryanf developmentofabiodegradablesubcutaneousimplantforprolongeddrugdeliveryusing3dprinting
AT larranetaeneko developmentofabiodegradablesubcutaneousimplantforprolongeddrugdeliveryusing3dprinting